Table 3.
Concomitant Use of Vitamin D Analogues During the Active Control Period
| FC (n = 281) | AC (n = 146) | SC (n = 78) | CA (n = 39) | SC + CA (n = 29) | |
|---|---|---|---|---|---|
| Week 12 | 224 (80) | 120 (82) | 67 (86) | 31 (79) | 22 (76) |
| Weeks 12-24 | 209 (74) | 111 (76) | 64 (82) | 26 (67) | 21 (72) |
| Weeks 24-36 | 182 (65) | 104 (71) | 59 (76) | 24 (62) | 21 (72) |
| Weeks 36-52 | 155 (55) | 85 (58) | 48 (62) | 22 (56) | 15 (52) |
Note: Values are given as number (percentage). Reported medications include alfacalcidol, calcitriol, doxercalciferol, and paricalcitol.
Abbreviations: AC, active control; CA, calcium acetate; FC, ferric citrate; SC, sevelamer carbonate; SC + CA, combination of sevelamer carbonate and calcium acetate.